Molecular defects in the pathogenesis of pituitary tumours

被引:61
作者
Levy, A [1 ]
Lightman, S [1 ]
机构
[1] Univ Bristol, Univ Res Ctr Neuroendocrinol, Bristol BS2 8HW, Avon, England
关键词
adenoma; clonality; aneuploidy; hypophysis; pituitary gland anterior; neuroendocrine; oncogenes;
D O I
10.1016/S0091-3022(03)00012-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The majority of pituitary adenomas are trophically stable and change relatively little in size over many years. A comparatively small proportion behave more aggressively and come to clinical attention through inappropriate hormone secretion or adverse effects on surrounding structures. True malignant behaviour with metastatic spread is very atypical. Pituitary adenomas that come to surgery are predominantly monoclonal in origin and roughly half are aneuploid, indicating either ongoing genetic instability or transition through a period of genetic instability at some time during their development. Few are associated with the classical mechanisms of tumour formation but it is generally believed that the majority harbour quantitative if not qualitative differences in molecular composition compared to the normal pituitary. Despite their prevalence and the ready availability of biopsy material, at the present time, the precise molecular pathogenesis of the majority of pituitary adenomas remains unclear. This review summarizes current thinking. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:94 / 127
页数:34
相关论文
共 542 条
[81]   Effects of the gp130 cytokines ciliary neurotropic factor (CNTF) and interleukin-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of prolactin and GH secretion in normal rat anterior pituitary aggregate cultures [J].
Castro, CP ;
Nagashima, AC ;
Pereda, MP ;
Goldberg, V ;
Chervin, A ;
Carrizo, G ;
Molina, H ;
Renner, U ;
Stalla, GK ;
Arzt, E .
JOURNAL OF ENDOCRINOLOGY, 2001, 169 (03) :539-547
[82]   Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas [J].
Chaidarun, SS ;
Klibanski, A ;
Alexander, JM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1058-1065
[83]   Positional cloning of the gene for multiple endocrine neoplasia-type 1 [J].
Chandrasekharappa, SC ;
Guru, SC ;
Manickam, P ;
Olufemi, SE ;
Collins, FS ;
EmmertBuck, MR ;
Debelenko, LV ;
Zhuang, ZP ;
Lubensky, IA ;
Liotta, LA ;
Crabtree, JS ;
Wang, YP ;
Roe, BA ;
Weisemann, J ;
Boguski, MS ;
Agarwal, SK ;
Kester, MB ;
Kim, YS ;
Heppner, C ;
Dong, QH ;
Spiegel, AM ;
Burns, AL ;
Marx, SJ .
SCIENCE, 1997, 276 (5311) :404-407
[84]   Absence of activating mutations in the GnRH receptor gene in human pituitary gonadotroph adenomas [J].
Chanson, P ;
De Roux, N ;
Young, J ;
Bidart, JM ;
Jacquet, P ;
Misrahi, M ;
Milgrom, E ;
Schaison, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 139 (02) :157-160
[85]   Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: A follow-up study [J].
Chanson, P ;
Daujat, F ;
Young, J ;
Bellucci, A ;
Kujas, M ;
Doyon, D ;
Schaison, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (07) :3009-3015
[86]   EXPRESSION CLONING OF A HUMAN CORTICOTROPIN-RELEASING-FACTOR RECEPTOR [J].
CHEN, RP ;
LEWIS, KA ;
PERRIN, MH ;
VALE, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :8967-8971
[87]  
Chen YM, 1999, J CELL PHYSIOL, V181, P385, DOI 10.1002/(SICI)1097-4652(199912)181:3<385::AID-JCP2>3.0.CO
[88]  
2-4
[89]   CYTOCHEMICAL STUDIES OF THE REGULATION OF ACTH-SECRETION [J].
CHILDS, GV .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 512 :248-274
[90]   CORTICOTROPIN-RELEASING HORMONE AND EPIDERMAL GROWTH-FACTOR - MITOGENS FOR ANTERIOR-PITUITARY CORTICOTROPES [J].
CHILDS, GV ;
ROUGEAU, D ;
UNABIA, G .
ENDOCRINOLOGY, 1995, 136 (04) :1595-1602